This article presents a study that could explain why some people react adversely to the Pfizer COVID-19 shots, and others do not. The authors from Denmark investigated the possibility of batch-dependent variation in light of the emergency-use authorization and large-scale vaccination programs of the COVID-19 “vaccines. The study was published as a Research Letter in the…
Tag: Pfizer BNT162b2
Excess Deaths in a Small Parish
This article shows how excess deaths can be seen at the local level of a parish in western New York. In the past two years, I suspected excess deaths in my town. Typically, the families of the deceased will give some of the donated flowers to the church after the funeral mass. My suspicions were…
Sky High Blood Sugars After the COVID Shots
This article features a study of patients admitted to the intensive care units due to dangerously high blood sugars after receipt of the COVID “vaccines.” The study was peer-reviewed and published in the Journal of the Endocrine Society. The authors are from the Albert Einstein College of Medicine in New York. In the case series,…
Acute Transverse Myelitis Cases after COVID Vaccinations
This article features several case reports of COVID-19-associated Acute Transverse Myelitis (ATM) following the COVID-19 vaccination. Anatomy Acute Transverse Myelitis is an inflammation of a segment of the whole spinal cord. The spinal cord comes from the brain and is divided into the cervical (neck), thoracic (chest), lumbar (lower back), and sacrococcygeal (tailbone) segments. Spinal…
Pfizer BNT162b2 adverse events as of February 28, 2021
The data for this article is taken from the Pfizer document, 5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021. The pdf link is embedded in the title. In it are the adverse events that are listed in The Complete List of the Pfizer Adverse Events of Special Interest that…
Autoimmune antibodies and diseases after COVID-19 disease and injections
A newly released study, Autoantibodies linked to autoimmune diseases associate with COVID-19 outcomes, discovered elevated autoantibodies in patients with moderate to severe COVID-19 infections.[1] The study included 248 adults from five states of the USA. One hundred seventy-one of them had COVID-19 symptoms and tested positive for SARS-CoV-2 by PCR testing. Seventy-seven are healthy controls. The…